• A Refined Population Pharmacokinetic Model-Based Guideline for Individualized PEGasparaginase Dosing in Pediatric Acute Lymphoblastic Leukemia
• Acute Pancreatitis in Pediatric Acute Lymphoblastic Leukemia (AcuPA Study): A Nationwide Survey in Poland
• Advancements in the Regulatory Role of microRNAs in Childhood Acute Lymphoblastic Leukemia: Mechanisms and Clinical Implications
• Advances in basic and clinical research of flumatinib
• Allogeneic stem cell transplant with TBI-based myeloablative conditioning in adolescents and young adults with Philadelphia chromosome-negative ALL treated with pediatric protocols
• An Optimized Peptide Antagonist of CXCR4 Limits Survival of BCR-ABL1-Transformed Cells in Philadelphia-Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia
• An unusual presentation of superior vena cava syndrome
• Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trial
• Artificial intelligence reveals the predictions of hematological indexes in children with acute leukemia
• Attention and executive functioning in children and adolescents treated for high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group (COG)
• Avatrombopag for severe refractory thrombocytopenia in a pediatric patient with ALL following allogeneic hematopoietic stem cell transplantation: A case report
• Bilateral Acute Proptosis With Papilledema and Sub-retinal Fluid As Initial Manifestations of Acute Lymphoblastic Leukemia in a Child
• Campylobacter jejuni bacteremia in a leukemic child: a nearly missed diagnosis
• Can we cure Ph+ ALL without chemotherapy or transplant?
• Cancer Statistics from the Shaukat Khanum Memorial Trust's Hospital-based Cancer Registry, Pakistan, 1994-2022: An Observational Study
• CAR-T treatment is safe and effective in adult patients with Down syndrome and B-cell acute lymphoblastic leukemia (B-ALL)
• Case report: An intriguing case of Philadelphia chromosome-positive acute lymphoblastic leukemia recurrence
• CD19 CAR T-cell therapy in relapsed TCF3-HLF-positive B-cell acute lymphoblastic leukemia
• Charting Health Challenges for Digital Preventive Interventions Among Adult Survivors of Childhood Acute Lymphoblastic Leukemia: National Long-Term Follow-Up Survey of Self-Rated Health Outcomes
• Childhood leukemia prevention within reach
• Comparative analysis of BCR::ABL1 p210 mRNA transcript quantification and ratio to ABL1 control gene converted to the International Scale by chip digital PCR and droplet digital PCR for monitoring patients with chronic myeloid leukemia
• Comparison of efficacy and safety of different asparaginases in adult acute lymphoblastic leukemia based on nano-magnetic beads immunoassay
• Comprehensive summary: the role of PBX1 in development and cancers
• Contribution of copy number to improve risk stratification of adult T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials
• Daratumumab in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: DELPHINUS Study
• Delineation of features, responses, outcomes, and prognostic factors in pediatric PDGFRB-positive acute lymphoblastic leukemia patients: A retrospective multicenter study
• Diagnostic value of procalcitonin in infections in patients with malignant hematologic diseases
• Differential effect of asparagine and glutamine removal on three adenocarcinoma cell lines
• Difficult Removal of a Stuck Chemoport Catheter of a Paediatric Patient in Post-Coronavirus Disease (COVID-19) Era - Management Strategies and Literature Review
• Dysregulated arginine metabolism in precursor B-cell acute lymphoblastic leukemia in children: a metabolomic study
• Dysuria and Vaginal Pain, Unusual Manifestations of B-acute Lymphoblastic Lymphoma
• Effective treatment of relapsed/refractory CD19-positive B/T-type mixed-phenotype acute leukemia with blinatumomab: A case report
• Enhanced depletion of MLL-fusion proteins in acute leukemia: potential for improved therapeutic outcomes
• Epigenetic Therapy in a Rare Ovarian Cancer - A Double-Edged Sword
• Ethyl Acetate Fraction from <em>Eleutherococcus divaricatus</em> Root Extract as a Promising Source of Compounds with Anti-Hyaluronidase, Anti-Tyrosinase, and Antioxidant Activity but Not Anti-Melanoma Activity
• Evaluation of the CCL17/CCL22-CCR4 axis in pediatrics with B-cell acute lymphoblastic leukemia before and after a chemotherapy course
• Expanding Beyond Genetic Subtypes in B-Cell Acute Lymphoblastic Leukemia: A Pathway-Based Stratification of Patients for Precision Oncology
• Exploration of the intracellular chiral metabolome in pediatric BCP-ALL: a pilot study investigating the metabolic phenotype of IgH locus aberrations
• Exploring the potential of IL-10 for risk assessment and early intervention in pediatric ALL
• Exploring the role of pain on physical activity among youth with acute lymphoblastic leukemia using the biopsychosocial model
• Feasibility and Favorable Responses Following Investigational CAR T-Cell Therapy for Relapsed and Refractory Infant ALL
• Genetic evidence for predisposition to acute leukemias due to a missense mutation (p.Ser518Arg) in ZAP70 kinase: a case-control study
• Genetic polymorphisms and their association with methotrexate polyglutamates during maintenance treatment in Korean children and young adults with acute lymphoblastic leukemia
• Genome-wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemia
• Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia
• Genomic structural variants analysis in leukemia by a novel cytogenetic technique: Optical genome mapping
• Glucocorticoid Sensitivity Among Young Survivors of Childhood Acute Lymphoblastic Leukemia: What Does It Matter?
• Health-related quality of life and its determinant factors in Thai children with cancer: parents vs. children perspectives
• Hematological Second Primary Malignancy in Pediatric Retinoblastoma: A Case Report and Systematic Review
• HERV-K np9 and HERV-R env: Two endogenous retrovirus products with potential Pathogenic roles in pediatric acute lymphoblastic leukemia
• Homoharringtonine synergizes with venetoclax in early T cell progenitor acute lymphoblastic leukemia: Bench and bed
• How I treat adult Ph-positive ALL
• Hypoxanthine in the microenvironment can enable thiopurine resistance in acute lymphoblastic leukemia
• Hypoxia-initiated Cysteine-rich protein 61 secretion promotes chemoresistance of acute B lymphoblastic leukemia cells
• Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining
• Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric acute lymphoblastic leukemia: results of a multicenter randomized trial
• Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic Leukemia
• Integrating rapamycin with novel PI3K/Akt/mTOR inhibitor microRNAs on NOTCH1-driven T-cell acute lymphoblastic leukemia (T-ALL)
• Intestinal mucositis, systemic inflammation and bloodstream infections following high-dose methotrexate treatment in childhood acute lymphoblastic leukaemia: Comparison between the NOPHO ALL 2008 protocol and the ALLTogether1 protocol
• L-asparaginase induces IP3R-mediated ER Ca(2+) release by targeting -OR1 and PAR2 and kills acute lymphoblastic leukemia cells
• Leukaemic Optic Neuropathy in a Patient with Treated Acute Lymphoblastic Leukaemia: Optical Coherence Tomography as an Aid to Diagnosis
• Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin
• Long-term exposure and response to azacitidine for post-hematopoietic stem cell transplantation relapse of early T-cell precursor acute lymphoblastic leukemia: a case report and review of the literature
• Long-Term Remission in T315I+ Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Blinatumomab and Allogeneic Stem Cell Transplantation: Two Case Studies
• Marginal Contribution of Pathogenic <em>RAD51D</em> Germline Variants to Pakistani Early-Onset and Familial Breast/Ovarian Cancer Patients
• Micro-costing of genetic diagnostics in acute leukemia in Sweden: from standard-of-care to whole-genome sequencing
• Minimal residual disease monitoring by Ig/TCR gene rearrangements predicts post-transplant relapse and survival in adult patients with acute lymphoblastic leukemia
• Molecular and cellular mechanisms of chemoresistance in paediatric pre-B cell acute lymphoblastic leukaemia
• Molecular characteristics and oncogenic role of CHD family genes: a pan-cancer analysis based on bioinformatic and biological analysis
• Molecular Mechanism of circVRK1 Regulating the Proliferation and Apoptosis of Acute Lymphoblastic Leukemia KOCL44 Cells by Targeting miR-4428
• Molecular pathology and computational profiling of Janus kinase 2 (JAK2) mutation in acute lymphoblastic leukemia: insights from a Pakistani cohort
• Myeloid sarcoma of the breast with synchronous early T-cell precursor acute lymphoblastic leukemia: A rare presentation
• Myeloid/lymphoid neoplasms with eosinophilia and FGFR1 rearrangement t(8;13)(p11;q12): A case report and literature review
• Novel thermoplastic microvalves based on an elastomeric cyclic olefin copolymer
• Occurrence and case fatality rate of invasive aspergillosis in children with acute leukemia: A systematic review and meta-analysis
• Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study
• Path-based reasoning for biomedical knowledge graphs with BioPathNet
• Patient-reported outcomes of treatment and adverse effects following acute lymphoblastic leukemia: a low- and middle-income country cross-sectional study
• Philadelphia chromosome-like acute lymphoblastic leukemia with concomitant rearrangements of CRLF2 and ABL1: a pediatric case report
• Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL)
• Prenatal origin of NUTM1 gene rearrangement in infant B-cell precursor acute lymphoblastic leukaemia
• Production Process Optimization of Recombinant <em>Erwinia carotovora</em>l-Asparaginase II in <em>Escherichia coli</em> Fed-Batch Cultures and Analysis of Antileukemic Potential
• Prognostic significance of CRLF2 in patients with acute lymphoblastic leukemia: a meta-analysis and systematic review
• Rare case of simultaneous occurrence of chronic neutrophil leukemia and T lymphoblastic lymphoma: case report and literature review
• Real-World Data on Childhood Relapsed Acute Lymphoblastic Leukemia: A Report on 100 Children Over two Decades From Southern India
• Safety and efficacy of blinatumomab as bridge-to-transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease
• Secondary acquisition of the Philadelphia chromosome in acute lymphoblastic leukemia
• Small Intestinal Complications of Intestinal Transplant-Associated Microangiopathy Post-stem Cell Transplantation
• Specific antigen-based stratification of membranous nephropathy in patients after haematopoietic stem cell allotransplantation - a case series and literature review
• Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohort
• Survival Outcomes in Older Adult Acute Lymphoblastic Leukemia Patients Analyzed by Facility Volume and Type: A National Cancer Database Analysis
• Symptomatic osteonecrosis in children treated for Hodgkin lymphoma: A population-based study in Sweden, Finland, and Denmark
• The characterization and the impact of CSF pleocytosis during blinatumomab therapy for adult acute lymphoblastic leukemia
• The clinical influence of complete remission with incomplete count recovery (CRi) on single-unit umbilical cord blood transplantation in patients with acute leukemia
• The evolution and history of Vinca alkaloids: From the Big Bang to the treatment of pediatric acute leukemia
• The genomic basis of childhood T-lineage acute lymphoblastic leukaemia
• TLE3 Is a Novel Fusion Partner of JAK2 in Myeloid/Lymphoid Neoplasm With Eosinophilia Responding to JAK2 Inhibition
• Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in Jehovah's witness patients
• Tumor-Suppressive Cross-Linking of Anti-T. cruzi Antibodies in Acute Lymphoblastic Leukemia
• Vascularized Transfer of Second Metacarpal Base for Treatment of Capitate Osteonecrosis